BGMA’s Smith Reflects On 25 Years Of Progress
UK Industry Leader Talks Generics Acceptance, Pricing And The Onset Of Biosimilars
Executive Summary
As Warwick Smith steps down after 25 years as leader of the British Generic Manufacturers Association, he talks about how far the country’s off-patent industry has come over the last quarter-century – including the acceptance of generics, the advent of biosimilars, and how freedom of pricing has helped to keep costs low while maintaining sustainable pricing – in the first part of an exclusive interview with Generics Bulletin.